Reports of patients denied prescribed medications on the rise due to policies and restrictions applied by Pharmacy benefits manager
PBM Denying Prescribed Medications – Judge, Jury, & Executioner?
Medication
Immunotherapy and Cancer
Could this be the silver bullet we’re looking for? Kathryn Vinson, MS, CCRC A couple of weeks ago, we talked…
Checkpoint inhibitors – the new direction for cancer drugs?
Most of the latest cancer drugs include the use of checkpoint inhibitors. This has turned into a multi-billion dollar insyrtry and the...
The Alternative Therapy Debate: Blessing or Curse
Every journey with cancer is different and no two are alike. What works for one may not work for another. The debate...
Drugs score big wins against lung, prostate, breast cancers
We are now starting to get news from ASCO conference in Chicago. New and improved drug are showing incredible promise for Lung,...
FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin
MERCK KEYTRUDA, THIS IS BIG NEWS! FDA anonounces for the first time an approval of a CANCER drug that targets genetic...
Top 20 Cancer Drugs
The face of cancer drugs has changed dramatically over the years. Nearly all of the top pharmaceutical companies are currently manufacturing oncology...
Merck’s Keytruda cancer drug records sales surge
Congratulations to Merck for the success of their Keytruda drug. Sales reflect the hope and success many are having with this immunotherapy...
Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade
Congratulations to Novartis on the success of Gleevec in treating chronic mylegenous leukemia (CML). 83% of people using it daily living on...
Big pharma faces costly setback in cancer fight
Investors lose billions as immunotherapies fall short of high expectations When Cary Parton pulled a back muscle playing golf four years ago,...
Biden to tackle broad range of cancer issues, including drug prices, after leaving White House
Vice President Biden, who led the Obama administration's "cancer moonshot" initiative, will create a nonprofit organization to grapple with a broad range...
Genentech takes on BMS — Merck with positive I/O lung cancer PhIII data
Genentech takes on BMS, Merck with positive I/O lung cancer PhIII data - Roche’s Genentech ($RHHBY) has rolled out positive Phase III...